Townhall··Saturday, November 21, 2026, 10:23 AM
New Cancer Study Shows Promising Results: 'Teaching the Immune System Lessons'
New drug FEBP-sTβRII boosts immune attack on tumors, showing 75% success in mice pancreatic cancer study.
Read the full story at Townhall
Opens townhall.com in a new tab.
What do you think?